Advertisement
Advertisement
U.S. markets close in 4 hours 8 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Codex DNA, Inc. (DNAY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.4600+0.3300 (+15.49%)
As of 11:52AM EDT. Market open.
Advertisement

Codex DNA, Inc.

9535 Waples Street
Suite 100
San Diego, CA 92121-2993
United States
858 228 4115
https://codexdna.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees264

Key Executives

NameTitlePayExercisedYear Born
Dr. Todd R. Nelson MBA, Ph.D.Pres, CEO & Director876.78kN/A1967
Ms. Jennifer Isacoff McNealey M.H.A.Chief Financial Officer417.44kN/A1973
Mr. Daniel G. Gibson Ph.D.Chief Technology Officer436.54kN/A1977
Mr. Eric EsserChief Operating OfficerN/AN/AN/A
Richard LepkeDirector of Investor RelationsN/AN/AN/A
Mr. Robert H. CutlerChief Legal OfficerN/AN/A1968
Ms. Laura B. Puga M.B.A.VP of People & CultureN/AN/A1980
Mr. Decky Goodrich M.B.A.Sr. VP of Commercial OperationsN/AN/AN/A
Mr. Laurence WardenSr. VP of Engineering & InstrumentationN/AN/AN/A
Mr. Dimas Jimenez M.B.A.VP & Corp. ControllerN/AN/A1970
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Corporate Governance

Codex DNA, Inc.’s ISS Governance QualityScore as of June 1, 2022 is 7. The pillar scores are Audit: 9; Board: 5; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement